Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes.
Sulphonylurea drugs are the therapy of choice for treating neonatal diabetes (ND) caused by mutations in the ATP-sensitive K(+) channel (KATP channel). We investigated the interactions between MgATP, MgADP, and the sulphonylurea gliclazide with KATP channels expressed in Xenopus oocytes. In the abse...
Үндсэн зохиолчид: | Proks, P, De Wet, H, Ashcroft, F |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2013
|
Ижил төстэй зүйлс
-
Phentolamine block of ATP-sensitive K+ channels does not involve interaction with the sulphonylurea receptor, SUR1.
-н: Proks, P, зэрэг
Хэвлэсэн: (1997) -
Interaction of MgATP with the sulphonylurea subunit activates ATP sensitive K-channels receptor
-н: Gribble, F, зэрэг
Хэвлэсэн: (1998) -
How ATP inhibits the open K(ATP) channel.
-н: Craig, T, зэрэг
Хэвлэсэн: (2008) -
Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
-н: Reimann, F, зэрэг
Хэвлэсэн: (2003) -
Mechanism of K-ATP channel inhibition by ATP
-н: Ashcroft, F, зэрэг
Хэвлэсэн: (1998)